TNF-α regulates corneal Langerhans cell migration

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4235-4239

  Dekaris, Iva ^a   Zhu, Su Ning ^a   Dana, M Reza ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL MIGRATION; GRAFT REJECTION; HERPES SIMPLEX KERATITIS; IMMUNE RESPONSE; LANGERHANS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CORNEA; INJECTIONS; INTERLEUKIN-1; LANGERHANS CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033120072     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Langerhans, P. 1868. Ueber die Nerven der menschlichen haut. Virchows Arch. Pathol. Anal. Physiol. 44:325.
2. Engelmann, T. W. 1910. Uber die Hornhaut des Auges (1867). In H. Graefe-Saemisch Handbuch der gesammten Augenheilkunde, 2nd Ed., Vol. 1. Leipzig, p. 30.
3. Gillette, T. E., J. W. Chandler, and J. V. Greiner. 1982. Langerhans cells of the ocular surface. Ophthalmology 89:700.
4. Jager, M. J., D. S. Gregerson, and J. W. Streilein. 1995. Regulators of immunological responses in Ihe cornea and the anterior chamber of the eye. Eye 9:241.
5. Asbell, P. A., and T. Kamenar. 1987. The response of Langerhans cells in the cornea to herpetic keratitis. Curr. Eye Res. 6:179.
6. Williamson, J. S. P., S. DiMarco, and J. W. Streilein. 1987. Immunobiology of Langerhans cells on the ocular surface. Invest. Ophthalmol. Vis. Sci. 28:1527.
7. McLeish, W., P. Rubsamen, S. A. Atherton, and J. W. Streilein. 1989. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. Reg. Immunol. 2:236.
8. Miller, J. K., K. A. Laycock, M. M. Nash, and J. S. Pepose. 1993. Corneal Langerhans cell dynamic after herpes simplex virus reactivation. Invest. Ophthalmol. Vis. Sci. 34:2282.
9. Niederkorn, J. Y. 1995. Effects of cytokine-induced migration of Langerhans cells on comeal allograft survival. Eye 9:215.
10. Sano, Y., B. R. Ksander, and J. W. Streilein. 1996. Minor H, rather than MHC, alloantigens offer the greater barrier to successful ortholopic corneal transplantation in mice. Transplant. Immunol. 4:53.
11. Sano, Y., B. R. Ksander, and J. W. Streilein. 1997. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest. Ophthalmol. Vis. Sci. 38:1130.
12. Yamada, J., M. R. Dana, S. N. Zhu, P. Alard, and J. W. Streilein. 1998. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch. Ophthahmol. 116:1351.
13. Dana, M. R., J. Yamada, and J. W. Streilein. 1997. Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation 63:1501.
14. Dana, M. R., R. Dai, S. Zhu, J. Yamada, and J. W. Streilein. 1998. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest. Ophthalmol. Vis. Sci. 39:70.
15. Jager, M. J., S. Atherton, D. Bradley, and J. W. Streilein. 1991. Herpetic slromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea. Curr. Eve Res. 10(Suppl.):69.
16. Jager, M. J. 1992. Corneal Langerhans cells and ocular immunology. Res. Immunol. 4:186.
17. Hendricks, R. L., M. Janowicz, and T. M. Tumpey. 1992. Critical role of corneal Langcrhans cells in the CD4-but not CDS-medialed immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:2522.
18. Jager, M. J., D. Bradley, S. Alberton, and J. W. Streilein. 1992. Presence of Langerhans cells in the central cornea linked to the development of ocular herpes in mice. Exp. Eye Res. 54:835.
19. Jager, M. J., D. S. Gregerson, and J. W. Streilein. 1995. Regulators of immunological responses in the cornea and the anterior chamber of the eye. Eye 9:241.
20. Gery, I., P. Davies, J. Derr, N. Krett, and J. A. Barranger. 1981. Relationship between production and release of lymphocyte-activating factor (interleukin-1) by murine macrophages. Cell. Immunol. 64:293.
21. Niederkorn, J. Y., J. S. Peeler, and J. Mellon. 1989. Phagocytosis of particulate antigens by corneal epithelial cells stimulate interleukin-I secretion and migration of Langerhans cells into the central cornea. Reg. Immunol. 2:83.
22. Sekine-Okano, M., R. Lucas, D. Rungger, T. DeKesel, G. E. Grau, P. M. Leuenberger, and E. Rungger-Brandle. 1996. Expression and release of tumor necrosis factor-α by explants of mouse cornea. Invest. Ophthalmol. Vis. Sci. 37:1302.
23. Cumberbatch, M., and I. Kimber. 1995. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensilization. Immunology 84:31.
24. Wang, B., S. Kondo S, G. M. Shivji, and H. Fugisawa. 1996. Tumour necrosis factor receptor II (p75) signaling is required for the migration of Langerhans' cells. Immunology 88:284.
25. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 92:388.
26. Le, J., and J. Vilcek. 1987. Biology of disease: tumour necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 56:234.
27. Eigler, A., B. Sinha, G. Hartmann, and S. Endres. 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 18:487.
28. Tartaglia, L. A., C. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendley, and M. A. Palladino Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
29. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
30. Rubsamen, P. E., J. P. McCulley, P. R. Bergstresser, and J. W. Streilein. 1984. On the la immunogenicity of mouse corneal allografts infiltrated with Langerhans cells. Invest. Ophthalmol. Vis. Sci. 25:513.
31. Streilein, J. W., G. B. Toews, and P. R. Bergstresser. 1979. Corneal allografts fail to express 1a antigens. Nature 282:326.
32. + Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J. Immunol. 136:4362.
33. Asbell, P. A., T. Kamenar, and J. David. 1986. The response of Langerhans cells in the cornea to the herpetic keratitis. Invest. Ophthalmol. Vis. Sci. (Suppl.)27: 133.
34. Kondo, S., and D. N. Sauder. 1997. Tumor necrosis factor (TNF) receptor type I (p55) is a main mediator for TNF-α-induced skin inflammation. Eur. J. Immunol. 27:1713.
35. Taub, D. D., and J. J. Openheim. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229.
36. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
37. Fukagawa, K., H. Saito, K. Tsubota, S. Shimmura, H. Tachimoto, A. Akasawa, and Y. Gguchi. 1997. RANTES production in a conjunctival epithelial cell line. Cornea 16:564.
38. Weiss, J. M., J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxix, N. Howells, M. Hofmann, G. Kohler, E. Schopf, H. Ponta, P. Herrlich, and J. C. Simon. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137.
39. Ma, J., J. H. Wang, Y. J. Guo, M. S. Sy, and M. Bigby. 1994. In vitro treatment with anti-I-CAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell. Immunol. 158:389.
40. Tang, A., M. Amagai, L. G. Granger, J. R. Stanley, and M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82.
41. Wang, B., H. Fujisawa, L. Zhuang, S. Kondo, G. M. Shivji, C. S. Kim, T. W. Mak, and D. N. Sauder. 1997. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:6148.
42. Trefzer, U., M. Brockhaus, H. Loetscher, F. Partlow, A. Kapp, E. Schopf, and J. Krutmann. 1991. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-I expression. J. Invest. Dermatol. 97:911.